Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|March 26, 2022
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipientsLucy Meunier, Mathilde Sanavio, Jérôme Dumortier, et al.Molecular Metabolism|April 3, 2022
Fibroblast growth factor 19 stimulates water intakeJosé Ursic-Bedoya, Carine Chavey, Guillaume Desandré, et al.Nature Communications|September 2, 2021
Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samplesHung-Ju Chang, Ana Zúñiga, Ismael Conejero, et al.JHEP Reports : Innovation in Hepatology|September 8, 2023
Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapseJules Daniel, Jérôme Dumortier, Arnaud Del Bello, et al.Annals of Intensive Care|April 30, 2026
Are King's College and Clichy-Villejuif criteria used for liver transplantation still appropriate? A retrospective study over a 25-year periodClément Monet, Laurène Fusi, Yassir Aarab, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 26, 2020
Alcohol Consumption the Day of Liver Transplantation for Alcohol-Associated Liver Disease Does Not Affect Long-Term Survival: A Case-Control StudyJosé Ursic-Bedoya, Jérôme Dumortier, Romain Altwegg, et al.JHEP Reports : Innovation in Hepatology|February 9, 2026
Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitisLucy Meunier, Clement Monet, Antonio Saviano, et al.Alimentary Pharmacology & Therapeutics|September 24, 2024
Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAMLina Hountondji, Stéphanie Faure, Pascale Palassin, et al.JHEP Reports : Innovation in Hepatology|May 4, 2023
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohortLina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2025
Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective StudyLucy Meunier, Bénédicte Delire, Eleonora De Martin, et al.Pageof 4